Nottingham, England Wednesday, February 18, 2026, 17:00 Hrs [IST] ...

EpiBiologics, a biotechnology startup developing protein degraders for cancer and immune diseases, has raised $107 million in funding to advance its lead program into the clinic. The company is ...

Swiss artificial intelligence startup Neural Concept SA said today it has raised $100 million in funding to rethink how products are designed and engineered with computer-aided design software tools.

"Understanding this dimension could help us design better drugs that don't just silence kinases but remove them altogether—and in some cases, it may explain unexpected effects of existing therapies." ...

Over the past few years, AbbVie’s ABBV neuroscience franchise has shifted from a secondary portfolio to a meaningful growth engine. The segment has consistently delivered double-digit growth, with its ...

Proteins play a key role not only in the body, but also in medicine: they either serve as active ingredients, such as enzymes or antibodies, or they are target structures for drugs. The first step in ...

Computer-aided drug design (CADD) began as a physics- and knowledge-driven discipline: docking, QSAR, pharmacophore modeling, and molecular dynamics (MD) provided a rational scaffold for hit finding ...

How are we improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule? The drug development pipeline is a costly and ...

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...